ARTICLE | Clinical News
Ch14 regulatory update
March 10, 2014 7:00 AM UTC
United Therapeutics said EMA accepted for review an MAA in December for Ch14.18 to treat neuroblastoma. This half, the company plans to submit a BLA to FDA for the chimeric mAb targeting GD2. Ch14.18 ...